DIEBOLD NIXDORF INC (DBD) Stock Fundamental Analysis
USA - NYSE:DBD - US2536512021 - Common Stock
64.5 USD
-1.1 (-1.68%)
64.5 USD
0 (0%)
Overall DBD gets a fundamental rating of 4 out of 10. We evaluated DBD against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. DBD has only an average score on both its financial health and profitability. DBD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year DBD was profitable.
In the past year DBD had a positive cash flow from operations.
DBD had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DBD reported negative operating cash flow in multiple years.
1.2 Ratios
DBD's Return On Assets of -0.34% is in line compared to the rest of the industry. DBD outperforms 60.00% of its industry peers.
The Return On Equity of DBD (-1.18%) is better than 71.43% of its industry peers.
DBD has a Return On Invested Capital of 8.61%. This is in the better half of the industry: DBD outperforms 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DBD is significantly below the industry average of 16.54%.
The last Return On Invested Capital (8.61%) for DBD is above the 3 year average (5.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROIC | 8.61% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
1.3 Margins
DBD's Operating Margin of 7.32% is fine compared to the rest of the industry. DBD outperforms 74.29% of its industry peers.
DBD's Operating Margin has improved in the last couple of years.
The Gross Margin of DBD (25.44%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of DBD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% |
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DBD is destroying value.
Compared to 1 year ago, DBD has about the same amount of shares outstanding.
Compared to 5 years ago, DBD has less shares outstanding
DBD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.91 indicates that DBD is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DBD (1.91) is comparable to the rest of the industry.
DBD has a debt to FCF ratio of 4.62. This is a neutral value as DBD would need 4.62 years to pay back of all of its debts.
DBD's Debt to FCF ratio of 4.62 is fine compared to the rest of the industry. DBD outperforms 65.71% of its industry peers.
DBD has a Debt/Equity ratio of 0.85. This is a neutral value indicating DBD is somewhat dependend on debt financing.
DBD has a worse Debt to Equity ratio (0.85) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.92
WACC9.37%
2.3 Liquidity
DBD has a Current Ratio of 1.36. This is a normal value and indicates that DBD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.36, DBD perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that DBD may have some problems paying its short term obligations.
With a Quick ratio value of 0.91, DBD perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
DBD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.90%.
DBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 69.69% yearly.
Looking at the last year, DBD shows a decrease in Revenue. The Revenue has decreased by -0.25% in the last year.
The Revenue has been decreasing by -3.18% on average over the past years.
EPS 1Y (TTM)-37.9%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%152.73%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%1.95%
3.2 Future
The Earnings Per Share is expected to grow by 11.87% on average over the next years. This is quite good.
Based on estimates for the next years, DBD will show a small growth in Revenue. The Revenue will grow by 2.83% on average per year.
EPS Next Y-3.97%
EPS Next 2Y13.81%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y2.32%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.57, which indicates a rather expensive current valuation of DBD.
82.86% of the companies in the same industry are more expensive than DBD, based on the Price/Earnings ratio.
DBD is valuated rather cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.90, DBD is valued correctly.
Based on the Price/Forward Earnings ratio, DBD is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 32.68. DBD is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.57 | ||
| Fwd PE | 12.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DBD is valued cheaper than 94.29% of the companies in the same industry.
DBD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DBD is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.72 | ||
| EV/EBITDA | 7.51 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.81%
EPS Next 3Y11.87%
5. Dividend
5.1 Amount
DBD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
64.5
-1.1 (-1.68%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners105.22%
Inst Owner Change-1.2%
Ins Owners1.78%
Ins Owner Change0.02%
Market Cap2.36B
Revenue(TTM)3.75B
Net Income(TTM)-12.90M
Analysts82.86
Price Target77.18 (19.66%)
Short Float %2.38%
Short Ratio4.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.65%
Min EPS beat(2)1.76%
Max EPS beat(2)59.55%
EPS beat(4)2
Avg EPS beat(4)0.05%
Min EPS beat(4)-52.17%
Max EPS beat(4)59.55%
EPS beat(8)5
Avg EPS beat(8)9.34%
EPS beat(12)7
Avg EPS beat(12)-88.46%
EPS beat(16)8
Avg EPS beat(16)-91.11%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)3.02%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)3.02%
Revenue beat(8)4
Avg Revenue beat(8)0.04%
Revenue beat(12)4
Avg Revenue beat(12)-0.96%
Revenue beat(16)4
Avg Revenue beat(16)-2.35%
PT rev (1m)0%
PT rev (3m)4.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.99%
EPS NY rev (1m)0%
EPS NY rev (3m)4.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.57 | ||
| Fwd PE | 12.9 | ||
| P/S | 0.64 | ||
| P/FCF | 11.72 | ||
| P/OCF | 10.43 | ||
| P/B | 2.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.51 |
EPS(TTM)3.67
EY5.69%
EPS(NY)5
Fwd EY7.75%
FCF(TTM)5.5
FCFY8.53%
OCF(TTM)6.18
OCFY9.59%
SpS100.25
BVpS29.95
TBVpS-9.82
PEG (NY)N/A
PEG (5Y)N/A
Graham Number49.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROCE | 10.9% | ||
| ROIC | 8.61% | ||
| ROICexc | 9.77% | ||
| ROICexgc | 29.69% | ||
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% | ||
| FCFM | 5.49% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
ROICexc(3y)6.13%
ROICexc(5y)6.88%
ROICexgc(3y)21.8%
ROICexgc(5y)29.05%
ROCE(3y)6.48%
ROCE(5y)7.06%
ROICexgc growth 3Y-11.73%
ROICexgc growth 5Y37.89%
ROICexc growth 3Y4.77%
ROICexc growth 5Y35.34%
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
F-Score4
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Debt/EBITDA | 2.31 | ||
| Cap/Depr | 18.6% | ||
| Cap/Sales | 0.68% | ||
| Interest Coverage | 2.84 | ||
| Cash Conversion | 56.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.91 |
F-Score4
WACC9.37%
ROIC/WACC0.92
Cap/Depr(3y)16.93%
Cap/Depr(5y)15.92%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.9%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%152.73%
EPS Next Y-3.97%
EPS Next 2Y13.81%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%1.95%
Revenue Next Year2.09%
Revenue Next 2Y2.32%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y3.35%
EBIT growth 3Y19.17%
EBIT growth 5Y36.19%
EBIT Next Year24.77%
EBIT Next 3Y13.69%
EBIT Next 5YN/A
FCF growth 1Y145.49%
FCF growth 3Y8.67%
FCF growth 5Y113.09%
OCF growth 1Y154.49%
OCF growth 3Y6.68%
OCF growth 5Y26.59%
DIEBOLD NIXDORF INC / DBD FAQ
What is the fundamental rating for DBD stock?
ChartMill assigns a fundamental rating of 4 / 10 to DBD.
What is the valuation status for DBD stock?
ChartMill assigns a valuation rating of 5 / 10 to DIEBOLD NIXDORF INC (DBD). This can be considered as Fairly Valued.
What is the profitability of DBD stock?
DIEBOLD NIXDORF INC (DBD) has a profitability rating of 4 / 10.
How financially healthy is DIEBOLD NIXDORF INC?
The financial health rating of DIEBOLD NIXDORF INC (DBD) is 4 / 10.
Can you provide the dividend sustainability for DBD stock?
The dividend rating of DIEBOLD NIXDORF INC (DBD) is 0 / 10 and the dividend payout ratio is 0%.